Toumaz to Exhibit at Embedded World 2011

ToumazToumaz, the leading provider of ultra-low energy wireless telemetry technologies for medical monitoring and internet-connected consumer devices, will be demonstrating its latest ultra-low energy wireless SoC TELRAN at Embedded World 2011 in Germany.

The Embedded World exhibition and conference takes place on 1 - 3 March 2011 at the Exhibition Centre Nürnberg Messe. Embedded World is the World's biggest exhibition of its kind and the meeting place of the international embedded community. The event showcases modern, leading-edge ideas and solutions to global challenges for which engineers and especially the developers of embedded systems bear special responsibility. The accompanying conference is the leading European event for the embedded industry and covers all fields of embedded system development. Toumaz will be exhibiting at the event for the first time and will be located at Stand 367 (Hall 12). On the show floor, attendees will be able to see demonstrations of Toumaz's innovative products, including wireless 3 axis accelerometer using the TZ1053TDK boards at 868MHz.

Toumaz has recently added to its expanding 'Connected Consumer' and Connected Healthcare product portfolio with the launch of TZ1053 TELRAN - an ultra-low energy radio for wireless sensor networks, environmental monitoring and smart metering. The portfolio also includes the SensiumTM vital signs monitoring platform, FENIX DAB+/DAB/FM CMOS RF IC and the XENIF all-in-one internet connected and broadcast audio SoC announced in September 2010.

Embedded World annually attracts 18,350 visitors from 66 countries and continues to grow each year. The event is the top worldwide platform for the industry to exchange ideas and source information at a high level.

Related news articles:

About Toumaz
Toumaz (AIM: TMZ) is pioneering low cost, ultra-low power wireless telemetry technologies for a wide range of markets including medical monitoring and internet-connected consumer devices.

Targeting the healthcare market, Toumaz's licensable smart sensor interface and transceiver platform, Sensium, is a leader in non-intrusive, real-time wireless monitoring of multiple physiological vital signs. Sensium offers the potential to transform medical monitoring and reduce the cost of healthcare by wirelessly connecting individuals to healthcare providers - simply, affordably and unobtrusively. Sensium provides the enabling technology for customers to create complete Body Area Networks based on ultra-low power, ultra-small size body-worn monitors. The Sensium system unlocks new product opportunities across a wide range of healthcare and lifestyle markets, including solutions for hospitals, care homes and telecare settings.

Toumaz also uses its ultra low power expertise to design silicon devices for wireless connectivity and internet-connected consumer products. Toumaz currently supplies FM/DAB radio chips and complete modules to market leaders in the digital radio market.

Toumaz has development centres in Oxford, UK and Taipei City, Taiwan.

Most Popular Now

Welcome Evo, Generative AI for the Genom…

Brian Hie runs the Laboratory of Evolutionary Design at Stanford, where he works at the crossroads of artificial intelligence and biology. Not long ago, Hie pondered a provocative question: If...

We could Soon Use AI to Detect Brain Tum…

A new paper in Biology Methods and Protocols, published by Oxford University Press, shows that scientists can train artificial intelligence (AI) models to distinguish brain tumors from healthy tissue. AI...

Telehealth Significantly Boosts Treatmen…

New research reveals a dramatic improvement in diagnosing and curing people living with hepatitis C in rural communities using both telemedicine and support from peers with lived experience in drug...

Research Study Shows the Cost-Effectiven…

Earlier research showed that primary care clinicians using AI-ECG tools identified more unknown cases of a weak heart pump, also called low ejection fraction, than without AI. New study findings...

AI can Predict Study Results Better than…

Large language models, a type of AI that analyses text, can predict the results of proposed neuroscience studies more accurately than human experts, finds a new study led by UCL...

New Guidance for Ensuring AI Safety in C…

As artificial intelligence (AI) becomes more prevalent in health care, organizations and clinicians must take steps to ensure its safe implementation and use in real-world clinical settings, according to an...

Remote Telemedicine Tool Found Highly Ac…

Collecting images of suspicious-looking skin growths and sending them off-site for specialists to analyze is as accurate in identifying skin cancers as having a dermatologist examine them in person, a...

Philips Aims to Advance Cardiac MRI Tech…

Royal Philips (NYSE: PHG, AEX: PHIA) and Mayo Clinic announced a research collaboration aimed at advancing MRI for cardiac applications. Through this investigation, Philips and Mayo Clinic will look to...

New Study Reveals Why Organisations are …

The slow adoption of blockchain technology is partly driven by overhyped promises that often obscure the complex technological, organisational, and environmental challenges, according to research from the University of Surrey...

Deep Learning Model Accurately Diagnoses…

Using just one inhalation lung CT scan, a deep learning model can accurately diagnose and stage chronic obstructive pulmonary disease (COPD), according to a study published today in Radiology: Cardiothoracic...

Shape-Changing Device Helps Visually Imp…

Researchers from Imperial College London, working with the company MakeSense Technology and the charity Bravo Victor, have developed a shape-changing device called Shape that helps people with visual impairment navigate...

Bayer Acquires HiDoc Technologies and Ca…

Bayer is today announcing that it plans to acquire HiDoc Technologies GmbH in the first quarter of 2025 and to start commercialization of the digital health application, Cara Care®. Cara...